Back

A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Insights into cardiac cell biology for repair and regeneration Microcirculation, Angiogenesis, Arteriogenesis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Ms Daniella Terenzi

St. Michael's Hospital, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail
ADGRL2 is an essential surface molecule for cardiac lineage specification and heart development
Professor H. Cho (Seoul, KR)
Abstract Slides
Presentation thumbnail
Osteopontin stimulates cell cycle in neonatal cardiomyocytes
Mr I. Rotem (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
In-vivo and vitro mitochondrial transfer from adipose-derived mesenchymal stem cell to ischemic cardiomyocyte
Doctor D. Mori (Osaka, JP)
Abstract Slides
Presentation thumbnail
The cardiac endothelial cell transcriptome in neonatal, adult, and remodeling hearts
Miss L. Dugaucquier (Antwerp, BE)
Abstract
Presentation thumbnail
Exosomes mediate myocardial regeneration of cardiac progenitor cells in a swine model of dilated cardiomyopathy
Doctor K. Hirai (Okayama, JP)
Abstract Slides

Access the full session

Session thumbnail
Insights into cardiac cell biology for repair and regeneration

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources